Aortic Devices & Clinical Trials

The University of Maryland Medical Center, along with its partner the University of Maryland School of Medicine, is widely recognized for its significant research in the field of aortic disease. The UM Center for Aortic Disease is among a select few academic medical centers in the nation that are testing the next generation of diagnostic tools, surgical techniques, medications, and medical devices to treat aortic disease. This means that patients have access to the most innovative treatment options available anywhere.

Here is a sample of leading research devices which allow for minimally invasive surgical options for treatment of aortic disease underway at the University of Maryland Center for Aortic Disease:

• ARISE Trial: for treatment of dissection in the ascending aorta (thoracic aorta)
• Dual Branch Trial: for treatment of dissection of the aortic arch (thoracic aorta)
• Thoracic Branch Endoprosthesis (TBE Device): for treatment of lesions of the aortic arch and descending aorta (thoracic aorta)
• Thoracoabdominal Branch Endoprosthesis (TAMBE Device): for treatment of complex thoracic and abdominal aneurysms
• RelayBranch: for treatment of complex thoracic aortic pathologies involving the arch
• CheVAS Trial: for treatment of abdominal aneurysm with a medication or special blocking polymer
• ERAS (Endovascular Aortic Repair Study): an international study tracking the outcomes of minimally invasive aortic treatment
• IRAD (International Registry of Aortic Disease): an international database tracking the causes and outcomes of aortic dissection

For more information about available devices, current research projects, and to see whether you qualify, contact the UM Center for Aortic Disease at 410-328-4771.